Literature DB >> 19411060

Estrogen receptor-alpha polymorphisms and predisposition to TMJ disorder.

Margarete Cristiane Ribeiro-Dasilva1, Sérgio Roberto Peres Line, Maria Cristina Leme Godoy dos Santos, Mariana Trevisani Arthuri, Wei Hou, Roger Benton Fillingim, Célia Marisa Rizzatti Barbosa.   

Abstract

UNLABELLED: Temporomandibular joint disorders (TMJD) affect women with greater frequency than men, and sex hormones may contribute to this female predominance. Therefore, this study investigated whether estrogen receptor-alpha (XbaI/PvuII) single nucleotide polymorphisms (SNPs) are associated with TMJD in women. DNA was obtained from 200 women with TMJD (100 with chronic pain and 100 with signs of TMJD but no pain) diagnosed according to the Research Diagnostic Criteria for Temporomandibular Disorder (RDC/TMD) and 100 control women without TMJD. Restriction fragment length polymorphisms of polymerase chain reaction products were used to analyze XbaI and PvuII SNPs in DNA fragments. A model directly characterizing specific DNA sequence variants based on the risk haplotypic structure implemented with the EM algorithm was used to analyze the data. The [GC] haplotype of the XbaI locus was significantly more prevalent in both TMJD groups when compared with the control group (P = .0012). Specifically, the [GC] haplotype was more prevalent within the painful TMJD group versus the control group (OR = 3.203, 95% CI = 1.633, 6.284) and in the TMJD no pain versus the control group (OR = 2.51, 95% CI = 1.267, 4.97). In conclusion, the presence of [GC] haplotype in the XbaI locus may increase the susceptibility of women to develop TMJD. PERSPECTIVE: This study suggests that a polymorphism in the estrogen receptor may increase the risk of women developing temporomandibular joint disorder. This finding may elucidate the interindividual differences in the contribution of estrogen to TMJD, the genetic influences on TMJD predisposition, and may serve as the basis for future treatment tailoring, which could enhance outcomes for these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411060      PMCID: PMC2749669          DOI: 10.1016/j.jpain.2008.11.012

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  55 in total

Review 1.  Estrogen actions in the central nervous system.

Authors:  B S McEwen; S E Alves
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

2.  Association of cytosine-adenine repeat polymorphism of the estrogen receptor-beta gene with menopausal symptoms.

Authors:  Chikari Takeo; Etsuko Negishi; Aya Nakajima; Koichi Ueno; Ichiro Tatsuno; Yasushi Saito; Keiko Amano; Aizan Hirai
Journal:  Gend Med       Date:  2005-06

Review 3.  The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation.

Authors:  S Kopp
Journal:  J Oral Maxillofac Surg       Date:  1998-02       Impact factor: 1.895

4.  The prevalence of fibromyalgia in women aged 20-64 in Turkey.

Authors:  M Topbas; H Cakirbay; H Gulec; E Akgol; I Ak; G Can
Journal:  Scand J Rheumatol       Date:  2005 Mar-Apr       Impact factor: 3.641

5.  The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.

Authors:  Roger B Fillingim; Lee Kaplan; Roland Staud; Timothy J Ness; Toni L Glover; Claudia M Campbell; Jeffrey S Mogil; Margaret R Wallace
Journal:  J Pain       Date:  2005-03       Impact factor: 5.820

6.  Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype.

Authors:  N Laflamme; R E Nappi; G Drolet; C Labrie; S Rivest
Journal:  J Neurobiol       Date:  1998-09-05

7.  Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

Authors:  Luda Diatchenko; Gary D Slade; Andrea G Nackley; Konakporn Bhalang; Asgeir Sigurdsson; Inna Belfer; David Goldman; Ke Xu; Svetlana A Shabalina; Dmitry Shagin; Mitchell B Max; Sergei S Makarov; William Maixner
Journal:  Hum Mol Genet       Date:  2004-11-10       Impact factor: 6.150

8.  Expression of oestrogen receptor alpha and beta is higher in skeletal muscle of highly endurance-trained than of moderately active men.

Authors:  A Wiik; T Gustafsson; M Esbjörnsson; O Johansson; M Ekman; C J Sundberg; E Jansson
Journal:  Acta Physiol Scand       Date:  2005-06

9.  Peripheral effect of a kappa opioid receptor antagonist on nociception evoked by formalin injected in TMJ of pregnant rats.

Authors:  Mariana Trevisani Arthuri; Gustavo Hauber Gameiro; Cláudia Herrera Tambeli; Maria Cecília Ferraz de Arruda Veiga
Journal:  Life Sci       Date:  2005-01-21       Impact factor: 5.037

10.  Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women.

Authors:  Arjan P Bergink; Joyce B van Meurs; John Loughlin; Pascal P Arp; Yue Fang; Albert Hofman; Johannes P T M van Leeuwen; Cornelia M van Duijn; André G Uitterlinden; Huibert A P Pols
Journal:  Arthritis Rheum       Date:  2003-07
View more
  24 in total

1.  Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.

Authors:  Shad B Smith; Dylan W Maixner; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charles Knott; Gary D Slade; Eric Bair; Dustin G Gibson; Dmitri V Zaykin; Bruce S Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Infusion of Gabrα6 siRNA into the trigeminal ganglia increased the myogenic orofacial nociceptive response of ovariectomized rats treated with 17β-estradiol.

Authors:  P R Kramer; L L Bellinger
Journal:  Neuroscience       Date:  2014-08-12       Impact factor: 3.590

3.  GABAergic influence on temporomandibular joint-responsive spinomedullary neurons depends on estrogen status.

Authors:  A Tashiro; D A Bereiter; R Thompson; Y Nishida
Journal:  Neuroscience       Date:  2013-12-04       Impact factor: 3.590

4.  Genes in the GABA Pathway Increase in the Lateral Thalamus of Sprague-Dawley Rats During the Proestrus/Estrus Phase.

Authors:  Mikhail Umorin; Crystal Stinson; Larry L Bellinger; Phillip R Kramer
Journal:  J Cell Physiol       Date:  2015-09-30       Impact factor: 6.384

5.  Daily Fluctuations of Progesterone and Testosterone Are Associated With Fibromyalgia Pain Severity.

Authors:  Meredith Schertzinger; Kate Wesson-Sides; Luke Parkitny; Jarred Younger
Journal:  J Pain       Date:  2017-12-14       Impact factor: 5.820

6.  ENPP1 and ESR1 genotypes associated with subclassifications of craniofacial asymmetry and severity of temporomandibular disorders.

Authors:  Kay Chung; Tabitha Richards; Romain Nicot; Alexandre R Vieira; Christiane V Cruz; Gwénaël Raoul; Joel Ferri; James J Sciote
Journal:  Am J Orthod Dentofacial Orthop       Date:  2017-11       Impact factor: 2.650

7.  ENPP1 and ESR1 genotypes influence temporomandibular disorders development and surgical treatment response in dentofacial deformities.

Authors:  Romain Nicot; Alexandre R Vieira; Gwénaël Raoul; Constance Delmotte; Alain Duhamel; Joël Ferri; James J Sciote
Journal:  J Craniomaxillofac Surg       Date:  2016-07-21       Impact factor: 2.078

8.  Estrogen Selectively Enhances TMJ Disc but Not Knee Meniscus Matrix Loss.

Authors:  Y Park; S Chen; N Ahmad; T Hayami; S Kapila
Journal:  J Dent Res       Date:  2019-09-17       Impact factor: 6.116

9.  Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study.

Authors:  Shad B Smith; Ellen Mir; Eric Bair; Gary D Slade; Ronald Dubner; Roger B Fillingim; Joel D Greenspan; Richard Ohrbach; Charles Knott; Bruce Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

10.  Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint.

Authors:  Jyoti Puri; Bob Hutchins; Larry L Bellinger; Phillip R Kramer
Journal:  Reprod Biol Endocrinol       Date:  2009-12-31       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.